BioNTech SEBNTXNASDAQ
Loading
Operating Cash Flow Growth AcceleratingAccelerating
Percentile Rank87
3Y CAGR+192.1%
Year-over-Year Change
Year-over-year operating cash flow growth rate
3Y CAGR
+192.1%/yr
Quarterly compound
Percentile
P87
Within normal range
vs 3Y Ago
24.9x
Strong expansion
Streak
2 qtr
Consecutive growthAccelerating
| Period | Value |
|---|---|
| Q3 2025 | 546.75% |
| Q2 2025 | 116.08% |
| Q1 2025 | -63.94% |
| Q4 2024 | 27.13% |
| Q3 2024 | -139.10% |
| Q2 2024 | 610.86% |
| Q1 2024 | -140.48% |
| Q4 2023 | 4.88% |
| Q3 2023 | -81.51% |
| Q2 2023 | 747.58% |
| Q1 2023 | -181.69% |
| Q4 2022 | -82.65% |
| Q3 2022 | 21.94% |
| Q2 2022 | -3.24% |
| Q1 2022 | 2130.18% |
| Q4 2021 | -113.29% |
| Q3 2021 | 1596.31% |
| Q2 2021 | 67.78% |
| Q1 2021 | -224.89% |
| Q4 2020 | 229.49% |
| Q3 2020 | -1141.94% |
| Q2 2020 | 71.66% |
| Q1 2020 | 14.03% |
| Q4 2019 | -29.27% |
| Q3 2019 | 9.64% |
| Q2 2019 | -74.49% |
| Q1 2019 | -1027.78% |
| Q4 2018 | -119.40% |
| Q3 2018 | 140.95% |
| Q2 2018 | 0.00% |
| Q1 2018 | 0.00% |